Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies [Phase 4]
A Phase 4 clinical trial evaluating rFVIIIFc for immune tolerance induction in hemophilia A patients with inhibitors who previously failed I…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Alphanate in Immune Tolerance Induction Therapy [Phase 2]
Phase 2 trial update for Alphanate in immune tolerance induction therapy was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: BT200 in Hereditary Bleeding Disorders [Phase 2]
Phase 2 trial update for BT200 in hereditary bleeding disorders has completed, investigating von Willebrand disease and Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A [Phase 3]
Open-label Phase 3 trial evaluating safety and efficacy of recombinant Factor VIII in adults with severe Hemophilia A; study completed with …
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: BAX 802 in CHA With Inhibitors [Phase 3]
Phase 3 trial of BAX 802 in Hemophilia A was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg [Phase 3]
A single-arm Phase 3 trial evaluating valoctocogene roxaparvovec at 4e13 vg/kg in Hemophilia A has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ
Non-interventional post-authorisation study assessing immunogenicity, safety, and efficacy of NUWIQ in Hemophilia A has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B [Phase 2]
Phase 2 clinical trial updating coagulation factor VIIa variant marzeptacog alfa (activated) in adults with hemophilia A or B with inhibitor…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 [Phase 2, Phase 3]
Clinical trial update on pharmacokinetics, efficacy, and safety of recombinant and protein-free Factor VIII (rAHF-PFM) in Hemophilia A patie…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B [Phase 2]
Phase 2 trial update on a next-generation recombinant Factor IX variant for Hemophilia B; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B [Phase 4]
Phase 4 trial update evaluating nonacog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with Hemophil…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: PF-06741086 Long-term Treatment in Severe Hemophilia [Phase 2]
Phase 2 long-term treatment trial for PF-06741086 in severe Hemophilia A or B has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia [Phase 1]
Phase 1 trial update for marzeptacog alfa (activated), a coagulation factor VIIa variant, in adults with hemophilia showing completed status…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors [Phase 3]
Phase 3 trial evaluating safety and tolerability of prophylactic emicizumab in Hemophilia A patients with inhibitors has completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 [Phase 2, Phase 3]
A continuation study evaluating recombinant and protein-free Factor VIII (rAHF-PFM) in pediatric Hemophilia A patients conducted in Canada; …
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients [Phase 4]
Phase 4 trial update for Moroctocog Alfa (AF-CC) in prophylaxis and treatment of bleeding episodes in previously treated Hemophilia A patien…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: China ADVATE PTP Study [Phase 4]
Phase 4 clinical trial update for ADVATE in China, completed study under Baxalta/Shire sponsorship for Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients [Phase 3]
Phase 3 trial evaluating pharmacokinetics, efficacy, and safety of IMMUNATE SD (human plasma-derived Factor VIII concentrate) in Hemophilia …
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A [Phase 2, Phase 3]
A pediatric pharmacokinetics and efficacy/safety study of recombinant Factor VIII (rAHF-PFM) in Hemophilia A has completed Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: IMMUNINE Pre-Treatment Study [Phase 4]
Phase 4 clinical trial update for IMMUNINE pre-treatment study, completed in Hemophilia B.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Optimizing the Use of Prophylaxis in Patients With Severe Haemophilia A [Phase 4]
Phase 4 clinical trial update evaluating optimized prophylaxis in patients with severe Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures [Phase 4]
Phase 4 trial update on emicizumab prophylaxis in participants with Hemophilia A undergoing minor surgery; study terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors [Phase 2]
Phase 2 study of BAY1093884 in adults with Hemophilia A or B with or without inhibitors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients [Phase 1]
Phase 1 dose-escalation study assessing safety, pharmacokinetics, and pharmacodynamics of ISU304/CB2679d in adults with Hemophilia B; study …
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients [Phase 4]
Phase 4 clinical trial update evaluating recombinant coagulation factor IX with recombinant albumin (rIX-FP) in severe Hemophilia B patients…